Peer Review History
| Original SubmissionAugust 25, 2020 |
|---|
|
PONE-D-20-26647 Periodontal pathogens alter the synovial proteome Periodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice PLOS ONE Dear Dr. Müller-Hilke, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 14 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, David Douglass Brand Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please download the ARRIVE Guidelines 2.0, "Essential 10" checklist and submit it with your revision. You may find it here: https://arriveguidelines.org/resources/author-checklists. 3.Thank you for stating the following in the Acknowledgments Section of your manuscript: [Purchase of the Illumina MiSeq was kindly supported by the EU-EFRE (European Funds for Regional Development) program and funds from the University Medicine Rostock awarded to BK.] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [The author(s) received no specific funding for this work.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. Additional Editor Comments (if provided): In reviewing this manuscript, both reviewers have suggested that a significant revision is in order before this work is ready for publication. Each reviewer has provided many different areas that they have suggested will strengthen the work. As academic editor, I would mirror the comments provided by reviewer 1 at the conclusion of the review. While it is very important to report all findings in a study and to draw the best conclusions possible from those findings, if some of those findings are in direct contrast to previously published works (as is the case here) it is important to use the discussion section to compare and contrast the methods, reagents and anything else that might differ between the studies so that the appropriate conclusions can be drawn. It in no way means that one study is right and the other is wrong, it's just that the interpretations should include a careful consideration of all existing data. There is clearly a very complex relationship between periodontal disease and arthritis, and this complexity is compounded by the use of rodent models to allow us to dissect some of these relationships and mechanisms. This makes it imperative to have multiple perspectives from different laboratories approaching the problem. I would encourage you to take these reviews into consideration as you revise this important work. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript “Periodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice” aims to analyze the synovial proteome by using a model of arthritis and oral infection with two periodontopathogenic bacteria. Overall, the manuscript is well-done and results bring novelty to the literature, however, there are some concerns that need be addressed. --The major point refers to the experimental design. While it is quite interesting, the accurately comparison between all groups is limited. The authors used two distinct models, one with PD induced first CIA and other with PD induced after CIA. In both situations, significant changes in oral microbiome are expected. What remains undetermined is the oral load of Aa and Pg in these situations. Were the differences between Aa and Pg CIA groups a result of the capacity of oral colonization of these bacteria? It is pivotal to link findings to systemic and joint inflammation. Moreover, the bacterial translocation is an event reported in the course of arthritis and periodontal disease, and this would account for differences in synovia proteome. Authors should address these points to support the hypothesis. --The objectives of study are not clearly outlined in abstract and introduction. --Introduction should focus in the main subject of study. --While the experimental groups are clearly represented in Fig 1 the, the parameters of these groups were not consistently presented in the results section as pointed bellow. The subheadings of results section also require revision. A standardization of group’s nomenclature throughout the manuscript is necessary. --Fig 2A, authors show the anti-Aa and anti-Pg ab production, in animals inoculated with respective bacteria. Did the authors perform this measurement in the course of CIA? It would be interesting to demonstrate the dynamic of Ab production in CIA/PD or PD/CIA groups. The justification that CIA mice were not included because of possible interferences of immunization and boost in the presence of Freund´s adjuvant is not justified since appropriated controls were included in all experiments to solve these problems. --Fig 2C, please show microscopic images for Aa group. Importantly, please present data regarding alveolar bone loss for all groups. --Line 133. Authors state that “Unfortunately, the minute anatomy of the murine oral cavity did not allow for the assessment of acute gingivitis and periodontitis in live animals. We therefore concentrated on antibodies against oral pathobionts, systemic cytokines and the gastrointestinal microbiome as proxies for successful colonization in the course of the experiments and evaluated gingival histology and alveolar bone loss at endpoint.” Please re-state it because these parameters may be assessed in periodontal tissues by a number of methods including histology, immunohistochemistry, biochemical assays (e.g. ELISA, MPO) and others and some of these were used in the study. --Line 149-150. Please specify what means “neither signs of inflammation nor bacterial nests containing Pg or Aa…” since only H&E stained histology sections, without using specific methods (e.g. immunostaining), do not allow the identification of these bacteria in periodontium. --Please describe variations in systemic cytokine responses presented in Fig. 2B. --Fig 3A. MicroCT images should be presented for all groups. Also, Indicate if sham is sham/CIA or sham/no CIA and the same for Pg. --Fig 4A. Given that synovia is one of the main focus of study, it is important to show histology for all groups. --Fig 4C in the left of heat map there is an identification of animals as Pg/noCIA (on lines 3 and 4) but on right column these animals are identified in the CIA group. Please check it. Also, if possible reorganize the order of animals to facilitate the data interpretation. --Fig 5B. In the groups in which PD was induced before arthritis, the time of second boost until the euthanasia was significantly lower compared to animals with PD induced after arthritis. Thus, it is expected that sham/CIA had lower arthritis incidence compared to CIA/sham. However the result is the opposite, about 70% for sham/CIA and 50% for CIA/sham. In the fig 5C the authors demonstrate that score for sham/CIA is lower than CIA/sham, what is coherent but not solve the apparent inconsistency seen in Fig 5B. --Fig 6A. Why no data from animals without CIA but with Pg and Aa oral inoculation were included? Were the CIA/Pg and Pg/CIA presented as one? These findings are important to draw the conclusion. --Data from the present study show important differences when compared with previous publications. For example, CIA groups exhibited almost no alveolar bone loss; few changes in joints were seen when Pg and Aa infection were performed before CIA. In contrast, previous studies account that arthritis per si induces alveolar bone loss and that Pg inoculation increases joint damage in CIA animals. Also, the lack of periodontal inflammation in Aa and Pg groups is dissimilar from previous literature. These differences should be discussed in details to substantiate further studies. Reviewer #2: Buschhart et al examined the relationship between periodontal disease and inflammatory arthritis in two experimental protocols, in one the periodontal disease was induced prior to induction of arthritis, and in the other arthritis was induced prior to periodontal disease. The authors examined the outcome of the two diseases in these two experimental protocols. The general take-home message is that, in these experimental set-ups, there was no effect of one disease on the other. These are still important findings to publish, however there are major concerns with the current version of the manuscript. This reviewer found the manuscript very difficult to follow, and that is the gist of many of the comments below. The other main problem is one of over-interpretation. Small differences that do not reach significance should not be presented as findings. This is true for the “slight” and “minor” changes found throughout – the major finding of the manuscript is that the diseases do not impact upon each other in mice under the experimental protocols presented. Unfortunately, the difference in synovial proteome touted in the title and abstract, lead the reader to expect a more robust finding. In fact, the proteomic analysis was conducted on a small subset of the experimental groups, and the significance shown is a comparison to sham treated mice (no CIA, no pd) rather than to mice that did not receive the bacteria but were immunized to collagen. Therefore, here too the interpretation is not justified. This is especially true given the important negative finding that pd does not worsen arthritis. Specific comments: The authors performed two independent experimental protocols, and show that nicely in figure 1. These protocols address independent questions! After that it is confusing whether we are being shown data from 1A or 1B or both – this has to be made very clear and it’s too confusing to show all joined together such as in 3B, especially since other figures like figure 4 are showing only the protocol of 1A. then figure 5 shows data for both protocols. It’s just too difficult to follow in this reviewer’s opinion. Best would be to show 1A and all the experimental evaluations of 1A, then show 1B and the evaluations of 1B. If there are comparisons between 1A and 1B (again these are independent questions, and performed independently), then that would come afterwards. Hard to follow the numbers in each group, and what was tested for each group. For example, figure 2A shows only sham vs. bacteria and the text provides the n of each group (large numbers for each group). Do these groups include +/-CIA? Figure 2B and 4C show heat maps but it’s unclear if the cytokine arrays were performed on all mice or only a select few mice per group. What was the actual group size for each endpoint measured? The heat maps also list individual mice not according to their group, further complicating the presentation. Some statistical comparison between groups is necessary to justify the conclusions that the authors present in the results section about induction or lack of induction of systemic inflammation. Line 135: It is unclear why the authors chose to analyze the gastrointestinal microbiome as a “proxy” for colonization of the oral cavity. They could have tested oral dysbiosis induced by Pg or Aa lavage – it has been shown by multiple groups that Pg induces an increase in the total anaerobic bacterial counts in the oral cavity detected by swabbing (no need to sacrifice the animals). Alternatively, they could have analyzed colonization of the oral cavity with the strains of bacteria they administered. Is there a reference for using the feces microbiome as a proxy for Pg or Aa colonization of the oral cavity? According to their results the gut microbiome did not reflect their intervention so what was learned? It’s confusing and misleading as presented. The suggestion that bacteria induced a “minor” change in the gut microbiome, without showing statistical significance, is not justified. Furthermore, despite showing no dysbiosis induced by CIA, in the discussion line 299 the result is presented as if CIA indeed induced perturbation of the gut microbiome. Line 185 reads “Figures 4A and B show macroscopic and histologic pictures of arthritic paws in mice that were subjected to periodontal disease induction before CIA” – actually what seems to be shown is one representative mouse of the control (no pd, no cia) group vs. one representative mouse of the CIA group (no pd). Therefore, the line is incorrect. In fact, what needs to be shown is the scoring of the CIA in all groups (caliper measurements, incidence and severity). Figure 3b should compare independently the CIA+bacteria group to the CIA-bacteria, and the CMC-CIA to bacteria-CIA. Presently the comparison groups together the +/-CIA groups in the sham vs Pg or Aas with and without CIA. Minor: The legends appear in the text rather than at the end. Line 395-400: clarify the method – are you administering the bacteria by gavage (in which case 25 ul does not seem realistic, and no gavage needle size is mentioned), or did you “apply” the bacteria? If applied, clarify what you mean. Line 401 – what is “initial” about this? Line 112 – as far as I understand it has not been demonstrated that systemic abx are necessary and indeed “facilitate colonization.” If you have a reference for this, please include. If not, please omit the claim. My understanding is that the model employs systemic abx based on the hypothesis that abx will facilitate colonization but that when it was tested the abx were shown not to be necessary. Line 186 – before jumping to cytokines the authors should say something about the arthritis incidence and scores – these should be shown. Last line of introduction – change synoviale to synovial Line 412 “tree” should be “three” ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Periodontal pathogens alter the synovial proteome Periodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice PONE-D-20-26647R1 Dear Dr. Müller-Hilke, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, David Douglass Brand Academic Editor PLOS ONE Additional Editor Comments (optional): The authors have made a very significant effort toward responding to the criticisms provided by both reviewers as well as those I myself made in the primary review. I would agree with Dr. Müller-Hilke that the revisions have strengthened the work considerably. One final comment on this work is that the use of Tramadol, while an admirable attempt to relieve the pain experienced by the mice in the study, may have a significant effect on the study overall in that it is known to inhibit experimental inflammation (Eur J Pain. 2000;4(4):413-5. doi: 10.1053/eujp.2000.0208) the very endpoint that is measured in collagen-induced arthritis. This should be pointed out to the committee(s) that oversee animal welfare considerations and should be taken into consideration in the design of any future experiments that involve an inflammatory response. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-26647R1 Periodontal pathogens alter the synovial proteomePeriodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice Dear Dr. Müller-Hilke: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. David Douglass Brand Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .